PROCEPT BioRobotics (PRCT) Current Leases (2020 - 2026)

PROCEPT BioRobotics (PRCT) has reported Current Leases for 7 consecutive years, with $2.5 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Current Leases rose 21.66% year-over-year to $2.5 million in Q2 2026; TTM through Jun 2026 was $2.5 million, a 21.66% increase from a year earlier, with the FY2025 full-year figure at $2.2 million, up 15.92% from the prior year.
• Current Leases was $2.5 million for Q2 2026 at PROCEPT BioRobotics, up from $2.4 million in the prior quarter.
• Over five years, Current Leases peaked at $3.0 million in Q1 2023 and troughed at $1.7 million in Q4 2023.
• A 5-year average of $2.1 million and a median of $2.1 million in 2022 frame the typical range for Current Leases.
• Across the five-year window, Current Leases soared 37.46% in 2023 and plunged 43.26% in 2024, its largest moves.
• Over 5 years, Current Leases stood at $2.1 million in 2022, then decreased by 20.95% to $1.7 million in 2023, then increased by 13.49% to $1.9 million in 2024, then gained by 15.92% to $2.2 million in 2025, then climbed by 13.14% to $2.5 million in 2026.
• The last three Current Leases figures came in at $2.5 million (Q2 2026), $2.4 million (Q1 2026), and $2.2 million (Q4 2025), per Business Quant data.